ArticleThe Journal of antibiotics2026
Genome mining-based discovery of an atypical fungal non-reducing polyketide synthase encoding dimeric alkylresorcinol biosynthesis.
Article in The Journal of antibiotics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Biosynthesis of O-Prenylated Chaetophenols Triggers Nonenzymatic Pathways toward Structural Diversity.Organic letters · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Genome mining is a powerful strategy for finding biosynthetic gene clusters (BGCs) for unprecedented natural products and their biosynthetic mechanisms. In this study, to obtain novel type polyketides, we performed genome mining focusing on three perspectives for novelty: 1) amino acid sequence-based classification, 2) unique domain architectures of polyketide synthase, and 3) predicted structural features from protein modeling. As a result, we discovered a BGC consisting of a highly reducing polyketide synthase and a non-reducing polyketide synthase (NR-PKS), which harbors noncanonical tandem acyl carrier protein (ACP) domains and a structurally characteristic thioesterase (TE) domain. Heterologous expression revealed that the cyrl cluster produces a novel dimer of long-chain alkylresorcinolic acid (1). Furthermore, site-directed mutagenesis of each ACP domain revealed that both domains are essential for efficient dimerization. This study provides the first example of a fungal dimer-forming NR-PKS in which the tandem ACP domains work "in-series" with nonredundant roles to construct a dimeric long-chain alkylresorcinolic acid. The in silico analysis suggested that the TE domain led the substrate to a dimerizable form. Since 1 is structurally related to integracins with HIV-1 integrase inhibition, our findings provide insight into integracins biosynthesis and offer a basis for generating new integracin derivatives.
Indexed as
Identifiers
41535375What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.